相似文献
1
Abnormal metabolism of secondary bile acids in patients with cirrhosis.
Gut. 1970 May;11(5):420-2. doi: 10.1136/gut.11.5.420.
2
Biliary lipid composition in patients with porta cirrhosis of the liver.
Scand J Gastroenterol. 1980;15(7):849-52. doi: 10.3109/00365528009181540.
3
Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism.
Gastroenterology. 1975 Feb;68(2):335-41.
4
Serum, fecal and urinary bile acids in patients with mild and advanced liver cirrhosis.
Gastroenterol Jpn. 1981;16(5):506-13. doi: 10.1007/BF02774522.
5
Biliary lipid composition in patients with non-cirrhotic portal fibrosis--a comparison with compensated cirrhosis of the liver.
Liver. 1987 Feb;7(1):38-42. doi: 10.1111/j.1600-0676.1987.tb00313.x.
6
Mechanism of steatorrhoea in cirrhosis of liver: correlation between cholate concentration and BSP retention and vitamin B 12 excretion.
Indian J Med Res. 1972 Oct;60(10):1464-9.
7
Effect of cholecystokinin-Pancreozymin on bile salt secretion into the duodenal juice in patients with liver cirrhosis.
Klin Wochenschr. 1971 Aug 1;49(15):881-3. doi: 10.1007/BF01513474.
8
Biliary bile acid composition in Wilson's disease.
Mayo Clin Proc. 1975 May;50(5):229-33.
9
10
Sulfation and renal excretion of bile salts in patients with cirrhosis of the liver.
Gastroenterology. 1975 Mar;68(3):534-44.
引用本文的文献
1
Laparoscopic hepatectomy using indocyanine green attenuates postoperative inflammatory response for hepatocellular carcinoma: A propensity score matching analysis.
World J Gastrointest Surg. 2025 Jan 27;17(1):101793. doi: 10.4240/wjgs.v17.i1.101793.
2
Metabolomics analysis of patients with Schistosoma japonicum infection based on UPLC-MS method.
Parasit Vectors. 2024 Aug 20;17(1):350. doi: 10.1186/s13071-024-06429-9.
3
The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction.
Front Microbiol. 2022 May 10;13:909461. doi: 10.3389/fmicb.2022.909461. eCollection 2022.
4
Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.
J Clin Med. 2021 Jan 18;10(2):330. doi: 10.3390/jcm10020330.
5
Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection.
Biology (Basel). 2021 Jan 13;10(1):55. doi: 10.3390/biology10010055.
6
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.
Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):167-180. doi: 10.1038/s41575-020-00376-3. Epub 2020 Nov 30.
7
The role of gut microbiota in liver disease development and treatment.
Liver Res. 2019 Mar;3(1):3-18. doi: 10.1016/j.livres.2019.02.001. Epub 2019 Feb 20.
8
Usefulness of Simplified Nutritional Appetite Questionnaire (SNAQ) in Appetite Assessment in Elder Patients with Liver Cirrhosis.
J Nutr Health Aging. 2018;22(8):911-915. doi: 10.1007/s12603-018-1086-5.
9
Altered Microbiome in Patients With Cirrhosis and Complications.
Clin Gastroenterol Hepatol. 2019 Jan;17(2):307-321. doi: 10.1016/j.cgh.2018.08.008. Epub 2018 Aug 9.
10
Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
JCI Insight. 2017 Oct 5;2(19):94416. doi: 10.1172/jci.insight.94416.
本文引用的文献
1
The effect of oral neomycin on the conversion of cholic acid to deoxycholic in man.
Arch Biochem Biophys. 1963 Apr;101:7-13. doi: 10.1016/0003-9861(63)90527-7.
2
3
A simple method for the isolation and purification of total lipides from animal tissues.
J Biol Chem. 1957 May;226(1):497-509.
4
Turnover and nature of fecal bile acids in germfree and infected rats fed cholic acid-24-14C; bile acids and steroids 41.
Proc Soc Exp Biol Med. 1957 Mar;94(3):467-71. doi: 10.3181/00379727-94-22981.
5
Metabolism of desoxycholic acid in the rabbit. Bile acids and steroids, 28.
Acta Physiol Scand. 1955 Oct 27;34(2-3):287-94. doi: 10.1111/j.1748-1716.1955.tb01248.x.
6
Degradation of bile salts by human intestinal bacteria.
Gut. 1968 Feb;9(1):22-7. doi: 10.1136/gut.9.1.22.
Zotero 插件